United Therapeutics buy JPMorgan Chase & Co.
Start price
08.07.25
/
50%
€250.20
Target price
08.07.26
€281.09
Performance (%)
56.55%
Price
20.01.26
€399.30
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for United Therapeutics has seen massive gains of 56.55%. This prediction currently runs until 08.07.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -2.515% | -2.515% |
| iShares Core DAX® | -3.141% | 1.269% |
| iShares Nasdaq 100 | -3.518% | -1.355% |
| iShares Nikkei 225® | -3.396% | 3.283% |
| iShares S&P 500 | -2.943% | -0.533% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Corporation (NASDAQ: UTHR) had its price target lowered by analysts at JPMorgan Chase & Co. from $350.00 to $330.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€260.00
01.05.25
01.05.25
€309.54
01.05.26
01.05.26
53.58%
20.01.26
20.01.26
United Therapeutics
Start price
Target price
Perf. (%)
€255.00
21.04.25
21.04.25
€309.35
21.04.26
21.04.26
56.59%
20.01.26
20.01.26
United Therapeutics
Start price
Target price
Perf. (%)
€255.10
21.05.24
21.05.24
€276.33
21.05.25
21.05.25
6.82%
22.05.25
22.05.25